Scholarlink

Background <p>The gluten-free diet (GFD) has gained interest in recent years. While evidence showing that the GFD has a positive impact on everybody's health is weak, people with specific gluten-related disorders may benefit from it. As the only available treatment for celiac disease, the GDF can however not be followed without any additional cost.</p> Method <p>To measure it, we collected a rich database of gluten-free and gluten-containing products on the Swiss retail market. Using a hedonic pricing method, we disentangled the price of these products and estimated the gluten-free premium.</p> Results <p>We show that gluten-free products are on average 79% more expensive than regular products, which leads to an annual food-budget increase of CHF 421 (approx. the same in USD) (+ 77%) per patient.</p> Conclusion <p>These results highlight the need to reflect on the social policies accompanying celiac disease in Switzerland, as there is currently no support from the disability or health insurance for these patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The cost of being gluten-free: a hedonic pricing analysis of food products for celiac patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月24日

查看全文
  • Laia Soler,
  • Nicolas Borzykowski

摘要

Background

The gluten-free diet (GFD) has gained interest in recent years. While evidence showing that the GFD has a positive impact on everybody's health is weak, people with specific gluten-related disorders may benefit from it. As the only available treatment for celiac disease, the GDF can however not be followed without any additional cost.

Method

To measure it, we collected a rich database of gluten-free and gluten-containing products on the Swiss retail market. Using a hedonic pricing method, we disentangled the price of these products and estimated the gluten-free premium.

Results

We show that gluten-free products are on average 79% more expensive than regular products, which leads to an annual food-budget increase of CHF 421 (approx. the same in USD) (+ 77%) per patient.

Conclusion

These results highlight the need to reflect on the social policies accompanying celiac disease in Switzerland, as there is currently no support from the disability or health insurance for these patients.